665 results on '"Kilpatrick, Trevor"'
Search Results
2. Mertk-expressing microglia influence oligodendrogenesis and myelin modelling in the CNS
3. Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
4. Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system
5. High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS
6. White matter tract conductivity is resistant to wide variations in paranodal structure and myelin thickness accompanying the loss of Tyro3: an experimental and simulated analysis
7. The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3.
8. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
9. Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease
10. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice
11. Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
12. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
13. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome
14. The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK
15. The oligodendrocyte-enriched orphan G protein-coupled receptor Gpr62 is dispensable for central nervous system myelination
16. The clinical profile of NMOSD in Australia and New Zealand
17. Nanodiamonds with silicon vacancy defects for non-toxic photostable fluorescent labeling of neural precursor cells
18. HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.
19. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
20. The Patient‐Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.
21. Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study.
22. Patient‐determined disease steps is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis
23. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
24. Multiple Sclerosis: Basic and Clinical
25. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
26. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study
27. EphA4 (Sek1) Receptor Tyrosine Kinase is Required for the Development of the Corticospinal Tract
28. DNA methylation signatures of Multiple Sclerosis occur independently of genetic risk and are primarily attributed to B cells and monocytes
29. Cell Death in the Schwann Cell Lineage and its Regulation by Neuregulin
30. Comparative effectiveness of autologous hematopoietic stem cell transplant vs Fingolimod, Natalizumab, and Ocrelizumab in highly active relapsing-remitting multiple sclerosis
31. Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus.
32. DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.
33. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity
34. Microglial Function in MS Pathology
35. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies
36. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations
37. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy
38. Early predictors of visual and axonal outcomes after acute optic neuritis
39. 2326 Differential methylation mediates significant proportions of environmental and lifestyle factors’ associations with MS risk: results from the Ausimmune case-control study
40. 2413 Does serum neurofilament light chain level contribute to the prediction of treatment response in multiple sclerosis?
41. 2367 Developing tolerogenic dendritic cells as immunotherapy for multiple sclerosis
42. Clinical impact of whole-genome sequencing in patients with early-onset dementia
43. Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system
44. Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic
45. Achievements and obstacles of remyelinating therapies in multiple sclerosis
46. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
47. Higher consumption of ultra-processed foods and increased likelihood of central nervous system demyelination in a case-control study of Australian adults.
48. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study
49. Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation
50. Gait stability reflects motor tracts damage at early stages of multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.